Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT

Freigegeben

Zeitschriftenartikel

Strontium-modification of porous scaffolds from mineralized collagen for potential use in bone defect therapy

MPG-Autoren
/persons/resource/persons126855

Simon,  Paul
Paul Simon, Chemical Metal Science, Max Planck Institute for Chemical Physics of Solids, Max Planck Society;

Externe Ressourcen
Es sind keine externen Ressourcen hinterlegt
Volltexte (beschränkter Zugriff)
Für Ihren IP-Bereich sind aktuell keine Volltexte freigegeben.
Volltexte (frei zugänglich)
Es sind keine frei zugänglichen Volltexte in PuRe verfügbar
Ergänzendes Material (frei zugänglich)
Es sind keine frei zugänglichen Ergänzenden Materialien verfügbar
Zitation

Quade, M., Schumacher, M., Bernhardt, A., Lode, A., Kampschulte, M., Voss, A., et al. (2018). Strontium-modification of porous scaffolds from mineralized collagen for potential use in bone defect therapy. Materials Science & Engineering C, 84, 159-167. doi:10.1016/j.msec.2017.11.038.


Zitierlink: https://hdl.handle.net/21.11116/0000-0001-2E99-0
Zusammenfassung
The present study describes the development and characterization of strontium(II)-modified biomimetic scaffolds based on mineralized collagen type I as potential biomaterial for the local treatment of defects in systemically impaired (e.g. osteoporotic) bone. In contrast to already described collagen/hydroxyapatite nanocomposites calcium was substituted with strontium to the extent of 25, 50, 75 and 100 mol% by substituting the CaCl2-stock solution (0.1 M) with SrCl2 (0.1 M) during the scaffold synthesis. Simultaneous fibrillation and mineralization of collagen led to the formation of collagen-mineral nanocomposites with mineral phases shifting from nanocrystalline hydroxyapatite (Sr0) over poorly crystalline Sr-rich phases towards a mixed mineral phase (Sr100), consisting of an amorphous strontium phosphate (identified as Collin's salt, Sr6H3(PO4)5 ∗ 2 H2O, CS) and highly crystalline strontium hydroxyapatite (Sr5(PO4)3OH, SrHA). The formed mineral phases were characterized by transmission electron microscopy (TEM) and RAMAN spectroscopy. All collagen/mineral nanocomposites with graded strontium content were processed to scaffolds exhibiting an interconnected porosity suitable for homogenous cell seeding in vitro. Strontium ions (Sr2 +) were released in a sustained manner from the modified scaffolds, with a clear correlation between the released Sr2 + concentration and the degree of Sr-substitution. The accumulated specific Sr2 + release over the course of 28 days reached 141.2 μg (~ 27 μg mg− 1) from Sr50 and 266.1 μg (~ 35 μg mg− 1) from Sr100, respectively. Under cell culture conditions this led to maximum Sr2 + concentrations of 0.41 mM (Sr50) and 0.73 mM (Sr100) measured on day 1, which declined to 0.08 mM and 0.16 mM, respectively, at day 28. Since Sr2 + concentrations in this range are known to have an osteo-anabolic effect, these scaffolds are promising biomaterials for the clinical treatment of defects in systemically impaired bone.